
|
Nanogate, an international nanotechnology enabler, is strengthening its sales potential through its equity holding in Sarastro GmbH and is expanding its technical expertise to include bio-compatible solutions. Through the transaction the enabler is initially acquiring 25.1 % of the shares from the founders of Sarastro GmbH. In a notarised contract, Nanogate has already secured the increase of its stake in the company to 51%. The option can be exercised in the coming years. The nanotechnology company Sarastro specialises in manufacturing antimicrobial and medically compatible surfaces. Both companies plan to enhance materials, surfaces and products for various applications with new biological properties and in doing so offer solutions for a dynamically growing market. |